Tests of a potential cancer therapy tested on terminally ill patients is being hailed as offering ‘extraordinary results’, by leading scientists.
According to Sky News, more than nine out of ten participants in the study with a severe form of leukaemia saw their symptoms completely vanish, while four out of five patients with other blood cancers responded positively to the treatment.
More than half of these patients remained symptom free post trial.
Lead Professor Stanley Riddell, from the Fred Hutchinson Cancer Research Center in Seattle, US, added that the trial therapy was tested on patients with a prognosis of just two to five months to live:
"This is extraordinary. This is unprecedented in medicine to be honest, to get response rates in this range in these very advanced patients."
The treatment saw sciences remove immune cells called T-cells from patients, tagging them with molecules that target cancer, and putting them back into the body in an infusion.
The molecules, taken from specially bred genetically engineered mice, reduced the ability of the cancer to shield itself from the body's natural immune system.
The study cautioned that although the results are massively promising, there is no indication for how long the symptom-free patients would remain in remission.
New studies have found that the HPV vaccine has saved hundreds of lives from cervical cancer. New research has found that children who were vaccinated at age 12-13 against HPV have a ‘close to zero’ risk of dying from cervical cancer before age 30. The study, the first of its kind, showed that cervical cancer […]
This Spotlight Oral Care offer is one you can’t miss out on As much as I’d love to fly over and back to America to stock up on all the beauty essentials in Target, it just isn’t sustainable or affordable. We’ve been searching high and low to find something as good as the Crest whitening […]
Endometriosis impacts one in 10 women in Ireland For thousands of women across the globe, getting an endometriosis diagnosis can take several years of scans, appointments and invasive surgeries. However, researchers at Oxford University have developed a new scan technique which may help spot the lifelong condition sooner. The technique uses specialised CT scans, which […]
